AISLING CAPITAL MANAGEMENT LP
Adviser information for AISLING CAPITAL MANAGEMENT LP last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 12 |
---|---|
Investment Advisory/Research | 8 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 3 | $515.7M |
Non-Discretionary | 0 | $0 |
Total | 3 | $515.7M |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 2 | $510.6M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 1 | $5.1M |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 0 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Principal Office
489 FIFTH AVENUE10TH FLOOR
NEW YORK
NY
United States
Monday - Friday, 9:00 AM - 5:00 PM
Tel: 212-651-6380, Fax: None
Chief Compliance Officer
ROBERT WENZEL
CHIEF FINANCIAL OFFICER
489 FIFTH AVENUE
10TH FLOOR
NEW YORK
NY
United States
Tel:
212-651-6374
R******@*****************M
(Full email address available in API data)
Regulatory Contact
CAROL ZIKOPOULOS
HEAD OF HR/COMPLIANCE MANAGER
489 FIFTH AVENUE
10TH FLOOR
NEW YORK
NY
United States
Tel:
212-651-6382
C**********@*****************M
(Full email address available in API data)
Industry Affiliates
AISLING CAPITAL LLC | Other investment adviser, including financial planners |
AISLING CAPITAL PARTNERS IV, LP | Sponsor, GP, manager of pooled investment vehicles |
AISLING CAPITAL PARTNERS V, LP | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
AISLING CAPITAL IV, LP | Private Equity Fund | $317.2M | $5.0M | 24 |
AISLING CAPITAL V, LP | Private Equity Fund | $193.5M | $5.0M | 39 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
SCHIFF, ANDREW, NEWMAN | Individual | – | CO-PRESIDENT | 08/2015 | 50-75% |
SCHIFF, ANDREW, NEWMAN | Individual | AISLING CAPITAL PARTNERS IV LLC | MEMBER | 08/2015 | 50-75% |
ELMS, STEVEN, ARNOTE | Individual | – | CO-PRESIDENT | 08/2015 | 50-75% |
WENZEL, ROBERT, JOHN | Individual | – | CHIEF COMPLIANCE OFFICER / CHIEF FINANCIAL OFFICER | 04/2017 | < 5% |
AISLING CAPITAL PARTNERS IV LLC | Domestic Entity | – | GENERAL PARTNER | 08/2015 | < 5% |
ELMS, STEVEN, ARNOTE | Individual | AISLING CAPITAL PARTNERS IV LLC | MEMBER | 08/2015 | 50-75% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 8th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
Aclaris Therapeutics Inc (ACRS) | COM | 478K | 434K | – |
Biomea Fusion Inc (BMEA) | COM | 4M | 799K | – |
BridgeBio Pharma Inc. (BBIO) | COM | 154M | 6M | – |
CalciMedica, Inc. (CALC) | COM NEW | 2M | 521K | – |
Compass Pathways Plc (CMPS) | SPONSORED ADS | 6M | 965K | – |
Elevation Oncology Inc (ELEV) | COM | 8M | 3M | – |
Marker Therapeutics, Inc. (MRKR) | COM NEW | 2M | 314K | – |
Monte Rosa Therapeutics Inc (GLUE) | COM | 6M | 1M | – |
Nuvation Bio Inc. (NUVB) | COM CL A | 7M | 3M | – |
Poseida Therapeutics Inc. (PSTX) | COM | 3M | 1M | – |
Reneo Pharmaceuticals Inc (RPHM) | COM | 1M | 886K | – |
Syndax Pharmaceuticals, Inc. (SNDX) | COM | 21M | 1M | – |
Tectonic Therapeutic Inc (TECX) | COM | 1M | 84K | – |
Verona Pharma plc (VRNA) | SPONSORED ADS | 16M | 1M | – |
Viracta Therapeutics Inc (VIRX) | COM | 157K | 289K | – |